lung cancer molecular pathology of cancer boot camp january 4, 2012 jennifer rider, scd
TRANSCRIPT
Lung CancerMolecular Pathology of Cancer Boot CampJanuary 4, 2012Jennifer Rider, ScD
Learning objectives
•Basic descriptive epidemiology•Major risk factors•Historical perspective on establishing
smoking as a causal agent •Key differences in disease among smokers
and non-smokers
Five-year survival rates
ACS Cancer Facts & Figures 2011
Lung Cancer Epidemiology: Risk factors1. Cigarette smoking 2. Environmental tobacco smoke3. Radon4. Occupational exposures
a. Asbestos b. Asbestos x smoking interactionc. Cooking oil vapors and indoor coal burning
5. Ambient air pollution6. Genetic factors
Smoking▫Lung cancer risk depends on:
▫Years smoked▫Age smoking initiated▫Number of cigarettes smoked per day▫Tar/Nicotine
▫Risk roughly proportional to yield (down to one-half risk)
▫BUT negated by compensation in numbers smoked
▫Risk elevated in cigar/pipe smokers▫Amount smoked and inhaling contribute
Constituents of the cigarette
•7000 chemicals▫Carbon monoxide/vapor phase components▫Nicotine▫“Tar” = particulate – (nicotine + water)▫60 carcinogens▫Additives
Selected carcinogens in cigarette smoke•Policyclic aromatic hydrocarbons (PAH):
benzo[a]pyrene•Tobacco-specific nitrosamines (TSNA)•Aromatic amines: 4-aminobiphenyl•Benzene•Arsenic, Nickel, Chromium•Polonium-210
Smoking Cessation• Among individuals who have smoked less
than 20 years• Lung cancer risk reverts to non-smoker level
after about 15 years of cessation.• Among individuals who have already
developed lung cancer• Quitting reduces risks of developing a second
cancer
Lung cancer incidence and trends, and smoking behavior among men – United States
Tobacco Use in the US, 1900-1999
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
Year
Per
Cap
ita C
igar
ette
Con
sum
ptio
n
0
10
20
30
40
50
60
70
80
90
100
Age
-Adj
uste
d Lu
ng C
ance
r D
eath
R
ates
*
*Age-adjusted to 2000 US standard population.
Source: Death rates: US Mortality Public Use Tapes, 1960-1999, US Mortality Volumes, 1930-1959, National Center for Health Statistics, Centers for Disease Control and Prevention, 2001. Cigarette consumption: Us Department of Agriculture, 1900-1999.
Per capita cigarette consumption
Male lung cancer death rate
Female lung cancer death rate
0%5%
10%15%20%25%30%35%40%45%
% s
mo
kers
Current smoking prevalence in US, 1965-1998
Smoking prevalence by sex
0%
10%
20%
30%
40%
50%
60%
70%
World East Asia/Pacific
U.S.
Men
Women
1933: JAMA begins to accept advertising for cigarettes
“Just as pure as the water you drink…and practically untouched by human hands.”
--Chesterfield advertisement, NY State
Journal of Medicine, 1933
“The following hints may prove helpful. In combination they are nearly perfect and 99 44/100% of the nicotine will go into the filter or your friends’ faces.” Consumer Reports, 1938
Barriers to acceptance of smoking-lung cancer relationship•Ecologic data - other plausible
alternatives•Smoking common in scientific community•Influence of tobacco companies•Novelty of epidemiological techniques•Strength of infectious disease model
▫Necessary and sufficient causes▫Isolate and identify agent▫Laboratory/animal evidence key▫Smoking associated with multiple diseases
A new model of causality
•Bradford Hill’s guidelines▫Strength of association▫Consistency▫Specificity▫Temporal sequence▫Dose-response/biologic gradient▫Biological plausibility▫Coherence▫Experimental evidence▫Analogy
•Active smoking accounts for 90% of lung cancer deaths, but only 10% smokers develop lung cancer
SmokingGenetic
Polymorphisms
Lung cancer risk
Lung Cancer Subtypes
•Squamous cell carcinoma•Adenocarcinoma•Large-cell carcinoma•Small-cell undifferentiated carcinoma
>90% of Lung
Cancers in US
Primarily adenocarcinoma
Primarily SCLC and squamous cell carcinoma
Sun et al., Nature Reviews Cancer 2007
Lung Cancer in Never Smokers
•Estimated 25% of lung cancers not attributable to smoking▫15% among men▫53% among women
•7th leading cause of cancer death worldwide
•Only relatively weak risk factors identified•Distinct histological, geographical and
gender distribution
Sun et al., Nature Reviews Cancer 2007
Proportion of Lung Cancer in Never Smokers
Sun et al., Nature Reviews Cancer 2007
Mutation profile among smokers vs. nonsmokers
Sun et al., Nature Reviews Cancer 2007
Gefitinib (Iressa) effectiveness among Asian patients with NSCLC
Lim et al., Br J Cancer 2005